ARTICLE

FindCenter AddIcon

How Ecstasy and Psilocybin Are Shaking Up Psychiatry

By Paul Tullis — 2021

Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.

Read on www.nature.com

FindCenter Post-Image

Experimental Treatments Changed the Course of the AIDS Epidemic; We Need the Same Approach to Mental Illness Today | Commentary

Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.

Article
Monnica Williams, Morgan Campbell
2021
FindCenter AddIcon
FindCenter Post-Image

A Dose of a Hallucinogen from a ‘Magic Mushroom,’ and then Lasting Peace

Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.

Article
Jan Hoffman
2016
FindCenter AddIcon
FindCenter Post-Image

Can Ketamine Treat Depression? the Answer May Lie in a Mysterious Brain Cell

To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.

Article
Sophie Putka
2021
FindCenter AddIcon
FindCenter Post-Image

Rapid Antidepressant Effects of the Psychedelic Ayahuasca Linked to Changes in Inflammatory Biomarkers

The antidepressant effects of the psychedelic brew known as ayahuasca appear to be related to anti-inflammatory activity, according to new research from scientists in Brazil.

Article
Eric W. Dolan
2021
FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research